Afamelanotide (CUV1647)

DRUG2 trials

Sponsors

Clinuvel Pharmaceuticals Limited

Conditions

Actinic KeratosesCarcinoma, Squamous CellOrgan Transplant RecipientsPolymorphic Light Eruption (PLE)

Phase 2

Phase II AK Study in Organ Transplant Patients

Clinuvel Pharmaceuticals LimitedActinic Keratoses, Carcinoma, Squamous Cell, Organ Transplant Recipients

Start: 2007-11-30End: 2012-08-31Target: 200Updated: 2010-12-06

Unknown Phase

Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

CompletedNCT00472901

Clinuvel Pharmaceuticals LimitedPolymorphic Light Eruption (PLE)

Start: 2007-05-31End: 2010-09-30Updated: 2011-10-05